Unknown

Dataset Information

0

Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration.


ABSTRACT: Background:Reporting mortality and lost to follow-up (LTFU) by age is essential as older HIV-positive patients might be at risk of long-term effects of living with HIV and/or taking antiretroviral therapy (ART). As age effects might not be linear and might impact HIV outcomes in the oldest more severely, people living with HIV (PLHIV) aged 50-59 years and PLHIV aged >60 years were considered separately. Setting:Seventeen adult HIV/AIDS clinics spread over nine countries in West Africa. Methods:Data were collected within the International Epidemiological Databases to Evaluate AIDS West Africa Collaboration. ART-naïve PLHIV-1 adults aged >16 years initiating ART and attending ?2 clinic visits were included (N=73,525). Age was divided into five groups: 16-29/30-39/40-49/50-59/?60 years. The age effect on mortality and LTFU was evaluated with Kaplan-Meier curves and multivariable Cox proportional hazard regressions. Results:At month 36, 5.9% of the patients had died and 47.3% were LTFU. Patients aged ?60 (N=1,736) and between 50-59 years old (N=6,792) had an increased risk of death in the first 36 months on ART (adjusted hazard ratio=1.66; 95% CI: 1.36-2.03 and adjusted hazard ratio=1.31; 95% CI: 1.15-1.49, respectively; reference: <30 years old). Patients ?60 years old tend to be more often LTFU. Conclusion:The oldest PLHIV presented the poorest outcomes, suggesting that the PLHIV aged >50 years old should not be considered as a unique group irrespective of their age. Tailored programs focusing on improving the care services for older PLHIV in Sub-Saharan Africa are clearly needed to improve basic program outcomes.

SUBMITTER: Bernard C 

PROVIDER: S-EPMC6247956 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration.

Bernard Charlotte C   Balestre Eric E   Coffie Patrick A PA   Eholie Serge Paul SP   Messou Eugène E   Kwaghe Viviane V   Okwara Benson B   Sawadogo Adrien A   Abo Yao Y   Dabis François F   de Rekeneire Nathalie N  

HIV/AIDS (Auckland, N.Z.) 20181116


<h4>Background</h4>Reporting mortality and lost to follow-up (LTFU) by age is essential as older HIV-positive patients might be at risk of long-term effects of living with HIV and/or taking antiretroviral therapy (ART). As age effects might not be linear and might impact HIV outcomes in the oldest more severely, people living with HIV (PLHIV) aged 50-59 years and PLHIV aged >60 years were considered separately.<h4>Setting</h4>Seventeen adult HIV/AIDS clinics spread over nine countries in West Af  ...[more]

Similar Datasets

| S-EPMC3104241 | biostudies-other
| S-EPMC3867284 | biostudies-literature
| S-EPMC6291755 | biostudies-literature
| S-EPMC3556242 | biostudies-literature
| S-EPMC4482391 | biostudies-literature
| S-EPMC2925143 | biostudies-literature
| S-EPMC8593822 | biostudies-literature
| S-EPMC7487031 | biostudies-literature
| S-EPMC3022522 | biostudies-literature
| S-EPMC5634924 | biostudies-literature